Posts by: Patricia Inacio, PhD

News

A Phase 1 clinical trial evaluating Eli Lilly’s investigational therapy LY3361237 in healthy people has dosed its first participant, Sanford Burnham Prebys Medical Discovery Institute (SBP) announced. The treatment is ... Read more

November 12, 2018November 12, 2018

Stem Cell Treatment Seen to Benefit Lupus Patients in Phase 1 Trial, New Study Opening

News

A single infusion of mesenchymal stem cells (MSCs) — those that make cells of the cartilage, bone, and fat — decreased the number of auto-reactive immune cells in difficult-to-treat systemic lupus ... Read more

August 27, 2018August 27, 2018

Urinary Levels of 3 Proteins Are Potential Biomarkers of Lupus Nephritis Progression, Study Suggests

News

The levels of three specific proteins in the urine may help predict kidney injury and outcomes in patients with lupus nephritis, a study reports. The study, “Composite urinary biomarkers to ... Read more

July 18, 2018

Clinical Trial Evaluating Stem Cells as Potential Treatment for SLE Granted NIH Funding

News

The Lupus Foundation of America and the National Institute of Allergy and Infectious Diseases (NIAID) are co-funding a five-year, Phase 2 trial that will investigate mesenchymal stem cells (MSCs) as a ... Read more

July 16, 2018July 16, 2018

Appendectomy Raises Risk of Lupus, Especially in Younger Women, Researchers in Taiwan Report

News

People who have had their appendix surgically removed, particularly younger women, are considerably more likely to develop systemic lupus erythematosus than those who have not had an appendectomy, researchers in Taiwan report. ... Read more

July 2, 2018July 2, 2018

EC4d Protein Levels Seen as Lupus Marker and Way to Monitor Disease Activity in Patients

News

Products derived from activating the complement pathway — a well-established player in the development of lupus — may server as a marker of disease activity and improve the monitoring ... Read more

June 6, 2018June 6, 2018

Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds

News

Obesity in women with systemic lupus erythematosus (SLE) is linked to worse disease activity, increased depression symptoms, and higher burden of pain and fatigue, a study reports. The study, ... Read more

June 1, 2018

FDA Clears Automated Diagnosis Tests for Lupus and ANCA-associated Vasculitis

News

The U.S. Food and Drug Administration (FDA) has approved new automated diagnostic tests for lupus and ANCA-associated vasculitis, a form of blood vessel inflammation, Grifols, which will market these tests, ... Read more

May 16, 2018May 16, 2018

Phase 1b Trial Begins Testing NKTR-358 in SLE Patients

News

The Phase 1b trial evaluating NKTR-358 — an investigational therapy that stimulates regulatory T-cell activation — in systemic lupus erythematosus (SLE) has begun dosing patients, Nektar Therapeutics announced. Unlike immunosuppressive therapies that ... Read more

April 18, 2018April 18, 2018

Atacicept Reduces Disease Burden in Lupus Patients with High Disease Activity, Study Shows

News

Treatment with 150 mg atacicept significantly improves outcomes in systemic lupus erythematosus (SLE) patients with high disease activity, data from a Phase 2b clinical trial show. The results of ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Phase 1 Trial Testing Safety of Potential Lupus Therapy, LY3361237, Underway

Stem Cell Treatment Seen to Benefit Lupus Patients in Phase 1 Trial, New Study Opening

Urinary Levels of 3 Proteins Are Potential Biomarkers of Lupus Nephritis Progression, Study Suggests

Clinical Trial Evaluating Stem Cells as Potential Treatment for SLE Granted NIH Funding

Appendectomy Raises Risk of Lupus, Especially in Younger Women, Researchers in Taiwan Report

EC4d Protein Levels Seen as Lupus Marker and Way to Monitor Disease Activity in Patients

Obesity in Women Worsens Lupus, Increases Depression, Pain and Fatigue, Study Finds

FDA Clears Automated Diagnosis Tests for Lupus and ANCA-associated Vasculitis

Phase 1b Trial Begins Testing NKTR-358 in SLE Patients

Atacicept Reduces Disease Burden in Lupus Patients with High Disease Activity, Study Shows

Pin It on Pinterest